Latus Bio in the news

Stay on top of breaking news from Latus Bio. Learn more about our industry & our company with in-depth and original news, interviews, & analysis and read what others are saying about us from news outlets around the globe.

Card Image

Latus Bio Announces Publication of Breakthrough Research on Novel AAV Capsid Variant for Huntington’s and Parkinson’s Disease Gene Therapy

Icon
Card Image

Latus Bio Unveils AAV-Ep+ Capsid Variant Capable of Unprecedented Protein Production in the Brain

Icon
Card Image

Current trends in gene therapy to treat inherited disorders of the brain

Icon
Card Image

Latus Bio Announces Data Presentations in Support of its Preclinical Huntington’s Disease Gene Therapy Program

Icon
Card Image

Latus Launches with State-of-the-Art Gene Therapy Development Technologies, Two Lead Product Candidates, and an Initial $54 Million in Series A Financing

Icon